➡ Fab'entech takes pride in its role as a key contributor in the fight against #CBRNthreats. Through collaborative efforts with EU member states and authorities, we are fully committed to provide cutting-edge #medicalcountermeasures to combat the deadliest #biologicalthreats.

✨ Happy new year! ✨ Fabentech has been through an incredible 2023 year, filled with achievements, challenges and growth. We are now welcoming 2024 and we are eager to keep fighting the #biologicalthreats by bringing #preparedness and response to the next level.

Happy new year! 🎉 2023 was a busy year with the launch of the HERA Invest financing mechanism and EU FAB network. In 2024, HERA will continue to reinforce supply of crucial #medicines, develop the next-gen #vaccine strategy and strengthen its strategic approach to #stockpiling

Fabentech is thrilled to introduce e-FabRIC, a consortium aimed at making a significant impact on European #pandemicpreparedness, funded by the European Commission ! linkedin.com/feed/update/ur… #emerginginfectiousdiseases #antiviral #sarbecovirus #medicalcountermeasure #biodefense

Fabentech partage son expertise en biodéfense avec les étudiants d’AgroParisTech ! 👨‍🎓👩‍🎓 🎯L’objectif : échanger avec les étudiants sur les #risquesbioterroristes et leurs impacts sur la santé humaine, ainsi que sur les réponses #sanitaires apportées. #biodefense #Sante

A strong reminder about #DiseaseX and the need for a fully operational medical response capable of treat #emerginginfectiousdiseases! Fabentech acknowledges the urgency of emergency preparedness and strives to provide #medicalcountermeasures against the next biological threats.

We're proud to honor the incredible women who make up 75% of our workforce! From the labs to production zone and executive committee, these women are driving innovation, and making a real difference in the fight against biological threats! #InternationalWomensDay2024

📢Fabentech is glad to attend the Conference in Strasbourg! Véronique Juillard, Fabentech’s Scientific Director, will take the stage and present our technology and how it offers a multifaceted shield against emerging biothreats. 🤝We are eager to meet you at there!

Fabentech invites prospective partners to engage on Investor Day, March, 20th! Sébastien IVA, Fabentech CEO, will be present : this is the opportunity to discover more about Fabentech’s ambitious vision, products and cutting-edge technology.

👉Fabentech se rend à #GLOBALINDUSTRIE, le rendez-vous business des acteurs de l’industrie d’aujourd’hui et de demain ! 🎙️Sébastien Iva a notamment pris la parole pour évoquer le sujet crucial de l’industrie du #biomédicament comme facteur de #souveraineté #NRBC #GI24

🔬 Fabentech au Forum Labo de Lyon : une journée riche en nouvelles perspectives ! Nous avons : 🔎 découvert les dernières avancées technologiques 🤝 consolidé nos liens avec nos fournisseurs 💬 échangé avec des acteurs clés du secteur Plus d'infos : forumlabo.com/lyon/fr-fr.html

Découvrez l’intervention de Sébastien Iva, CEO de Fabentech, au Global Industrie. A retenir: 👉 notre ambition de devenir le leader européen des immunothérapies d’urgence 👉le besoin d’un bouclier européen et souverain contre les menaces biologiques youtube.com/watch?v=cZi6-l…

Fabentech stands ready to deploy FabenFLU®, a fully-developed treatment designed to combat potential epidemics from the #AvianFlu virus. FabenFLU® showed broad neutralizing activity against a vast range of 20 virus clades, reinforcing the potency of polyclonal approach.

✨ Sébastien Iva will attend the EU HERA Info Days, and represent Fabentech expertise and ambition together with stakeholders of #healthpreparedness and response in Europe ! 🗓 April, 18th 2024 📍Paris, France More about the HERA Info Days : lnkd.in/gH3vTsJX

💊 Fabentech was present at the launch of the Critical Medicines Alliance, a pioneering initiative! We're dedicated to contributing to this essential cause, collaborating closely with European stakeholders to strengthen health security and resilience against #biologicalthreats.

WHO publishes the Bacterial Priority Pathogens List, incl. 15 families of antibiotic resistant pathogens, grouped into categories of priority for R&D. HERA's glad to support World Health Organization (WHO) for this prioritisation work, guiding 🌍 R&D and investment against #AMR 👉shorturl.at/BFhRB

🤝 Ready to connect and discover more about Fabentech lifesaving solutions against biological threats? Come and meet Sébastien IVA, CEO, and Grégory Vernier, Ph.D., Head of Business Development, who will attend the BIO International Convention in San Diego from June 3th to 6th!

Great discussion on health preparedness at NATO HQ today! Head of HERA Laurent Muschel had a productive exchange with NATO officials. A pleasure to see Dr Raed Arafat again! Together, we're better prepared to tackle global health challenges #NATO #HealthPreparedness #HERA

📢 Great achievement! Fabentech is thrilled to announce the launch and first results of first-in-human clinical trial for a antidote against a deadly plant-based toxin! 🔎To discover more about this exciting news, visit our linkedin post 👇: linkedin.com/posts/fab%27en…

🎙️Great presentation of Caroline Ballet at the 6th Edition of the #WorldCongressOnInfectiousDiseases! Caroline took the stage and shared the findings of Epic Crown 2 project. These results demonstrate the broadly neutralizing activity of #polyclonalantibody fragments.